Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.
about
Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeysAnalgesic Potential of Essential OilsBotulinum Toxin Type a as a Therapeutic Agent against Headache and Related DisordersMu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout miceConcurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis monosodium iodoacetate (MIA) modelHome cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female ratsEffects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.Automated assessment of pain in rats using a voluntarily accessed static weight-bearing testPain-Suppressed Behaviors in the Red-tailed Hawk 1 (Buteo jamaicensis).Effects of acute and sustained pain manipulations on performance in a visual-signal detection task of attention in rats.Evaluation of prescription opioids using operant-based pain measures in rats.Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents.Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: implications for preclinical behavioral assessment of chronic pain.Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in ratsEffects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.Lost but making progress--Where will new analgesic drugs come from?Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in ratsEffects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.The brain in chronic pain: clinical implications.Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in ratsBursting activity in myelinated sensory neurons plays a key role in pain behavior induced by localized inflammation of the rat sensory ganglionMechanical Conflict System: A Novel Operant Method for the Assessment of Nociceptive Behavior.Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys.Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.Effects of morphine on thermal sensitivity in adult and aged rats.Changes in saccharin preference behavior as a primary outcome to evaluate pain and analgesia in acetic acid-induced visceral pain in mice.Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.Evaluation of a Postoperative Pain-Like State on Motivated Behavior in Rats: Effects of Plantar Incision on Progressive-Ratio Food-Maintained RespondingEffects of ketoprofen, morphine, and kappa opioids on pain-related depression of nesting in mice.Effect of Hydroalcoholic Leaves Extract of Rhus Coriaria on Pain in Male RatsEmerging drugs in neuropathic pain.Anabolic-androgenic steroid effects on nociception and morphine antinociception in male rats.The application of conditioning paradigms in the measurement of pain.Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in ratsChronic pain alters drug self-administration: implications for addiction and pain mechanisms.
P2860
Q24681053-5D30C4E6-7EB7-44E0-BAE9-D8858555B9B9Q26772041-2723A759-D86F-438D-8B21-603919BB4154Q26781281-AAC49F1E-5C68-4324-B878-E795C0C3CB1CQ28533332-7761549B-BBAB-4C4F-A2CD-1343E2780A44Q28829244-55039888-E14B-4D38-8804-1CB38FEBE922Q30359897-5B479C79-F7B8-46B9-980A-0568D3781047Q30574567-4197D444-46DD-47BD-8997-D94B5203F220Q30666128-04816D56-518A-4975-B7CD-200D3CFB1BE7Q33696982-9101E5A3-834E-44C1-9FBB-0FBBAC1CC952Q33733502-9E99AE87-546A-4DB1-819C-63BE9290F8FDQ33821443-E1EFC7B1-C3E4-4B5A-B6DC-77FA19F231A8Q34104414-12DC6E4A-491A-4421-B867-71E6373FEACAQ34269299-DA6312D3-3B01-450D-AC4E-A1215290781DQ34390806-1EA8BDB3-06A8-4F60-8253-B64BD302DB1BQ34538792-BE051F98-6E82-4D09-927C-27AAFFCF98C7Q34714594-3475DA71-5682-4023-B065-D42F2FB6B1FEQ34946659-07E3E1DE-171E-43A9-A286-EE7EC55B43B0Q35039614-C3946E1A-7011-468E-95C0-5BE5EE6A670EQ35058471-36D96703-8557-4D7F-9FC3-67B3EDD19B0EQ35153858-21E8AD5F-658A-4DC8-9AFE-18306C5495F6Q35165606-C696F100-AAC0-4173-83BF-00A6E4262679Q35580854-25C982E6-9CA9-4617-9ECA-FC57BAA5CEA9Q35776817-3B3136CA-C983-494E-A3C6-EC100E1C16B6Q35803174-763D339B-8BC0-4249-BE05-0D5BE10C2A35Q35935827-8EB4288F-E590-46BB-A1A5-D63F5401369DQ35991181-CED1E86C-3971-4C41-AB95-96D933CBA160Q36057960-EC29135D-B0E1-4499-A023-349570ABD1AEQ36080183-794D92F0-649E-47CD-A813-30F593DF96E4Q36160403-1834DF86-C876-4CD4-880D-40892B744D9AQ36186198-515F8819-1521-4D18-A665-230B124C5FCDQ36333358-796402E3-B534-41CF-B11F-04DD5EFB9ADCQ36335488-18651CCC-7C1F-4C7C-A045-0DDB914030E2Q36470177-397E73FF-F014-407E-A79C-59C10914E3F2Q36616908-B11563A5-F25D-4189-86A1-A536BE2C0348Q36668442-D18D62ED-5953-4BC5-8096-7348D5E238E8Q36758590-E3489C93-37A6-4F1C-9468-A97577D0FF0DQ36966299-8E9772DF-5BFC-4D9D-8206-722F18D0A9BFQ37004516-A710469C-28A7-484A-9218-985EE74335B0Q37095221-FAF54E74-643B-4919-A8C2-370AAB260F9CQ37210763-C26F86C9-F5A4-4E2D-AFB2-ED977C9C2D64
P2860
Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Preclinical assessment of cand ...... dvances and future challenges.
@ast
Preclinical assessment of cand ...... dvances and future challenges.
@en
type
label
Preclinical assessment of cand ...... dvances and future challenges.
@ast
Preclinical assessment of cand ...... dvances and future challenges.
@en
prefLabel
Preclinical assessment of cand ...... dvances and future challenges.
@ast
Preclinical assessment of cand ...... dvances and future challenges.
@en
P2093
P356
P1476
Preclinical assessment of cand ...... advances and future challenges
@en
P2093
M R Brandt
T W Vanderah
P304
P356
10.1124/JPET.106.106377
P407
P577
2006-06-02T00:00:00Z